Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07901543

Feasibility Study of a Chatbot AI-Driven Preliminary Screening System for Hereditary Cancer Syndromes

Conditions: Hereditary Cancer Syndromes

Sex: All

Ages: 21 Years – 99 Years

Healthy volunteers: Yes

Enrollment: 200

Sponsor: National Cancer Centre, Singapore

Location: National Cancer Center Singapore Singapore

Summary

This study aims to assess the feasibility of implementing an AI-based hereditary cancer preliminary screening system that has already been developed. This validation cohort will consist of healthy individuals and cancer patients, including those already suspected to be at risk of hereditary conditions.

Eligibility Criteria

Inclusion Criteria: * Singapore citizen or permanent resident * Individuals from the general public or patients at NCCS * Adults (aged 21 or older) who are capable of giving informed consent Exclusion Criteria: * Under the age of 21 years old * Incapable of giving informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07901543). StuddyBuddy aggregates publicly available trial information.